Live Breaking News & Updates on Janssen Highlights Latest Research

Stay updated with breaking news from Janssen highlights latest research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Johnson & Johnson : 2023 Third-Quarter Press Release & Supplemental Schedules -October 17, 2023 at 06:45 am EDT

Media contact:

Investor contact:

. ....

Joaquin Duato , Tesia Williams , Jessica Moore , European Medicines Agency Seeking Approval , Exchange Commission , Drug Administration Seeking , European Academy Of Dermatology , Finalizes Separation Of Kenvue Inc , Johnson Announces Final Results Of Exchange , Janssen Highlights Latest Research , Consumer Health Company , Trueref Technology For Mapping , Nipocalimab Clinical Development Program To Address Unmet , Consumer Health , Interventional Solutions , Janssen To Highlight Latest Research , European Society Of Retina Specialists , European Commission Approves , European Medicines Agency , Company Consumer Health , Chief Executive , Innovative Medicine , Operational Sales , Net Earnings , Infectious Diseases , General Surgery ,

Johnson & Johnson Reports Q3 2023 Results

2023 Third-Quarter reported sales growth of 6.8% to $21.4 Billion with operational growth of 6.4% and adjusted operational growth of 4.9% . Operational growth excluding COVID-19 Vaccine of. ....

Joaquin Duato , Janssen To Highlight Latest Research , Finalizes Separation Of Kenvue Inc , Johnson Announces Final Results Of Exchange , Consumer Health , European Commission Approves , Interventional Solutions , Company Consumer Health , European Society Of Retina Specialists , Exchange Commission , European Medicines Agency Seeking Approval Of Erdafitinib , European Academy Of Dermatology , Janssen Highlights Latest Research , Consumer Health Company , Drug Administration Seeking Full Approval , European Medicines Agency , Chief Executive , Innovative Medicine , Infectious Diseases , General Surgery , New Announcements , Current Reports , Quarterly Reports , Annual Reports , Investor Relations , Multiple Atrial Fibrillation Ablation Products ,